SCHEMBL6523258

SCHEMBL6523258

COC(=O)/C(=C\c1cc(OC)c(OC)cc1Br)CC(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 1/20 0.49
KDM1A O60341 1/20 0.45
LCK P06239 1/20 0.44
FYN P06241 1/20 0.44
MAPT P10636 7/20 0.41
ALDH1A1 P00352 4/20 0.39
PRNP P04156 1/20 0.39
GAA P10253 1/20 0.39
ALOX12 P18054 1/20 0.39
HPGD P15428 3/20 0.39
LMNA P02545 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
BACE1 P56817 1/20 0.38
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA9 Q16790 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6523261 1.00 PRKDC (0.49) PRKDCKDM1ALCKFYNMAPT
SCHEMBL6523254 1.00 PRKDC (0.49) PRKDCKDM1ALCKFYNMAPT
SCHEMBL30655454 0.84 MAPT (0.37) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL7080563 0.82 MAPT (0.35) MAPTALDH1A1PRNPGAAALOX12
SCHEMBL7080565 0.82 MAPT (0.35) MAPTALDH1A1PRNPGAAALOX12
SCHEMBL6486683 0.76 MEN1 (0.45) MAPTALDH1A1GAAHPGDLMNA
SCHEMBL6486687 0.76 MEN1 (0.45) MAPTALDH1A1GAAHPGDLMNA
SCHEMBL6132092 0.75 GAA (0.55) MAPTALDH1A1GAAHPGDSMN1; SMN2
SCHEMBL6132093 0.75 GAA (0.55) MAPTALDH1A1GAAHPGDSMN1; SMN2
SCHEMBL8357109 0.74 ABCG2 (0.47) MAPTALDH1A1GAAHPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2252569-B1 ANTIINFECTIVE AND ANTITUMORAL COMPOUNDS ISOLATED FROM TROPICAL LIANAS JULIUS MAXIMILIANS UNIVERSITÄT WÜRZBURG (DE) 2016-10-05 EP disclosed
US-8877718-B2 Antiinfective and antitumoral compounds isolated from tropical lianas JULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG (DE) 2014-11-04 US disclosed
US-20110059911-A1 Antiinfective and Antitumoral Compounds Isolated From Tropical Lianas JULIUS-MAXIMILIANS-UNIVERSITAT WURZBURG (DE) 2011-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110059911-A1 Antiinfective and Antitumoral Compounds Isolated From Tropical Lianas NCL, SYNCRIP, MYC PRKDC 1894/4885KDM1A 3231/4885LCK 4367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.